Initial clinical experience with the first drug (sacubitril/valsartan) in a new class — angiotensin receptor neprilysin inhibitors in patients with heart failure with reduced left ventricular ejection fraction in Poland
2013 ◽
Vol 15
(11)
◽
pp. 1220-1227
◽
2011 ◽
Vol 33
(14)
◽
pp. 1750-1757
◽
2009 ◽
Vol 15
(9)
◽
pp. 782-789
◽
2017 ◽
Vol 6
(4)
◽
2017 ◽
Vol 6
(3)
◽